NEW! Next-generation T1 & ECV1 Mapping Designed to make advanced tissue characterization faster, simpler, and more accessible. Built on decades of cardiovascular MR expertise and shaped by customer feedback, T1…
Read MoreRead more about Hemodynamic Forces.
Read MoreLeiden, the Netherlands – February 2nd, 2026 – Medis Medical Imaging, a global leader in AI-powered cardiovascular imaging, today announced the appointment of Kevin DeMoss as VP Commercial QFR –…
Read MoreLeiden, the Netherlands – January 13th 2025 – Medis Medical Imaging, a global leader in advanced AI-powered solutions for cardiovascular imaging, proudly announces the appointment of Regina Beyhl as Head…
Read MoreMadrid, Spain – September 2nd, 2025 – Medis Medical Imaging today announced the interim results of the PIONEER IV trial, presented during the Late-Breaking Clinical Trials session at the European…
Read MoreLeiden, The Netherlands – June 23rd, 2025 – Medis Medical Imaging, a global leader in quantitative imaging solutions for cardiovascular diseases, proudly announces the appointment of Jason Fuller as Vice…
Read MoreLeiden, June 17th, 2025 – Medis Medical Imaging, a global leader in advanced solutions for cardiovascular imaging, proudly announces the appointment of Martijn van Lavieren, PhD as Head of Clinical…
Read MoreLeiden, The Netherlands – May 23, 2025 – Medis Medical Imaging today shares its view on the results of the REPEAT-QFR substudy of FAVOR III Europe, presented by Dr. Sophie…
Read MoreRaleigh, April 7th, 2025 – Medis Medical Imaging, the leading cardiac imaging software company, announces today the FDA clearance of the latest version of its groundbreaking Medis QFR® in the…
Read MoreTerumo Health Outcomes (THO), a division of Terumo Interventional Systems (TIS), and Medis Medical Imaging, a leading cardiac imaging software company, announced today that they have entered into a strategic partnership, in the United States, to enhance cardiovascular care through the utilization of both ePRISM – Terumo’s proprietary clinical decision support platform – and Medis’ Quantitative Flow Ratio (QFR) technology, a non-invasive software solution designed to assess angiography-derived coronary physiology.
Read More